James Kang

2.1k total citations
12 papers, 274 citations indexed

About

James Kang is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, James Kang has authored 12 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in James Kang's work include Breast Cancer Treatment Studies (2 papers), Neuropeptides and Animal Physiology (2 papers) and Breast Lesions and Carcinomas (2 papers). James Kang is often cited by papers focused on Breast Cancer Treatment Studies (2 papers), Neuropeptides and Animal Physiology (2 papers) and Breast Lesions and Carcinomas (2 papers). James Kang collaborates with scholars based in United States, Switzerland and Sweden. James Kang's co-authors include Eri S. Srivatsan, Marilene B. Wang, Chulho Kang, Barbara I. Kazmierczak, Isabella Rauch, Khatoun Al Moussawi, Russell E. Vance, Jeannette L. Tenthorey, Clifton L. Dalgard and Meera Srivastava and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Molecular Biology and European Journal of Biochemistry.

In The Last Decade

James Kang

11 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Kang United States 10 191 64 42 36 27 12 274
Hao Wei China 10 156 0.8× 91 1.4× 32 0.8× 12 0.3× 37 1.4× 15 327
Guangsen Fu United States 8 325 1.7× 19 0.3× 36 0.9× 36 1.0× 32 1.2× 11 386
Md Kamal Hossain United States 10 157 0.8× 150 2.3× 64 1.5× 57 1.6× 11 0.4× 17 406
Rodrigo Vargas Eguez United States 8 292 1.5× 37 0.6× 27 0.6× 17 0.5× 27 1.0× 9 399
Richard Bernasconi France 7 283 1.5× 31 0.5× 27 0.6× 29 0.8× 28 1.0× 9 428
Saptarshi Sinha India 13 233 1.2× 58 0.9× 194 4.6× 19 0.5× 49 1.8× 23 410
Nicholas J. Burgoyne United Kingdom 9 422 2.2× 50 0.8× 59 1.4× 60 1.7× 36 1.3× 9 591
Amol Kavishwar United States 12 222 1.2× 26 0.4× 32 0.8× 22 0.6× 133 4.9× 17 424
Bojing Zhu China 12 395 2.1× 146 2.3× 41 1.0× 45 1.3× 47 1.7× 26 541

Countries citing papers authored by James Kang

Since Specialization
Citations

This map shows the geographic impact of James Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Kang more than expected).

Fields of papers citing papers by James Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Kang. The network helps show where James Kang may publish in the future.

Co-authorship network of co-authors of James Kang

This figure shows the co-authorship network connecting the top 25 collaborators of James Kang. A scholar is included among the top collaborators of James Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Kang. James Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kang, James, Albert I. Ko, Jon Mallen‐St. Clair, et al.. (2022). EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1878(1). 188827–188827. 20 indexed citations
2.
Kang, James, et al.. (2020). Axillary Silicone Laden Lymph Nodes: an Unusual Cause of Lymphadenopathy Case Report. SN Comprehensive Clinical Medicine. 2(12). 2986–2990. 1 indexed citations
3.
Cattell, Renee, James Kang, Haifang Li, et al.. (2019). MRI Volume Changes of Axillary Lymph Nodes as Predictor of Pathologic Complete Responses to Neoadjuvant Chemotherapy in Breast Cancer. Clinical Breast Cancer. 20(1). 68–79.e1. 12 indexed citations
4.
5.
Kang, James, et al.. (2016). A review of gigaxonin mutations in giant axonal neuropathy (GAN) and cancer. Human Genetics. 135(7). 675–684. 18 indexed citations
6.
Rauch, Isabella, Jeannette L. Tenthorey, Khatoun Al Moussawi, et al.. (2016). NAIP proteins are required for cytosolic detection of specific bacterial ligands in vivo. The Journal of Experimental Medicine. 213(5). 657–665. 72 indexed citations
7.
Charnley, Adam K., M.A. Convery, Emma J. Jones, et al.. (2015). Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: Foundations for understanding inhibitor selectivity. Bioorganic & Medicinal Chemistry. 23(21). 7000–7006. 24 indexed citations
8.
Basak, Saroj K., Arthur W. Wu, Natarajan Venkatesan, et al.. (2015). Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells. Oncotarget. 6(21). 18504–18517. 60 indexed citations
9.
Xiong, Hui, James Kang, James M. Woods, et al.. (2010). Synthesis and SAR of sulfoxide substituted carboxyquinolines as NK3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(6). 1896–1899. 9 indexed citations
10.
Teplyakov, A., Galina Obmolova, Sheng‐Jiun Wu, et al.. (2009). Epitope Mapping of Anti-Interleukin-13 Neutralizing Antibody CNTO607. Journal of Molecular Biology. 389(1). 115–123. 29 indexed citations
11.
Kang, James, William Low, Thomas Norberg, et al.. (2004). Total chemical synthesis and NMR characterization of the glycopeptide tx5a, a heavily post‐translationally modified conotoxin, reveals that the glycan structure is α‐d‐Gal‐(1→3)‐α‐d‐GalNAc. European Journal of Biochemistry. 271(23-24). 4939–4949. 18 indexed citations
12.
Low, William, et al.. (2004). MALDI-MS analysis of peptides modified with photolabile arylazido groups. Journal of the American Society for Mass Spectrometry. 15(8). 1156–1160. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hao Wei Breakdown of academic impact, for papers by Guangsen Fu Breakdown of academic impact, for papers by Md Kamal Hossain Breakdown of academic impact, for papers by Rodrigo Vargas Eguez Breakdown of academic impact, for papers by Richard Bernasconi Breakdown of academic impact, for papers by Saptarshi Sinha Breakdown of academic impact, for papers by Nicholas J. Burgoyne Breakdown of academic impact, for papers by Amol Kavishwar Breakdown of academic impact, for papers by Bojing Zhu
Rankless by CCL
2026